WHO Approves Two New Drug to Treat COVID-19

Daily Current Affairs / WHO Approves Two New Drug to Treat COVID-19

Change Language English Hindi

Category : International Published on: January 17 2022

Share on facebook

The World Health Organization has approved two new drugs for two new COVID-19 treatments that will help expand its arsenal of vaccines as well as tools to prevent serious illness and virus deaths.
These two drug are baricitinib and casirivimab-imdevimab.
The WHO has recommended Eli Lilly & Co.’s rheumatoid arthritis drug and GlaxoSmithKline Plc’s monoclonal antibody.
Lilly's baricitinib drug is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis.

Justice B. R. Gavai is set to become the 52nd Chief Justice of India, succeeding Justice Sanjiv Khanna
Read More....
China halts deliveries of US-made Boeing jets, intensifying trade tensions between the two nations
Read More....
Daniel Noboa wins the presidential election in Ecuador, earning a full 4-year term.
Read More....
Blue Origin has successfully launched an all-female crew in space, setting a milestone in space exploration.
Read More....
SEBI has banned Gensol Engineering Ltd and its promoters over charges of fund misuse and price manipulation.
Read More....
Credit growth in India’s banking sector is expected to reach 12–13% in FY26 due to favorable policies and low interest rates.
Read More....
Morgan Stanley has revised India's GDP growth forecast for FY26 to 6.1% and cut the Sensex target due to global uncertainties.
Read More....
The 6th edition of the India-Uzbekistan joint military exercise "DUSTLIK-VI" begins at Aundh military base.
Read More....
The Ministry of Labour & Employment signed an MoU with Swiggy in New Delhi for worker welfare and support.
Read More....
Indian shooters Inder Singh Suruchi and Saurabh Chaudhary secured gold in the mixed team shooting event.
Read More....

WHO Approves Two New Drug to Treat COVID-19